⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12186004 | 1.00 | — | — | |
| SCHEMBL14943270 | 0.74 | — | — | |
| SCHEMBL327251 | 0.72 | — | — | |
| SCHEMBL3434947 | 0.71 | — | — | |
| SCHEMBL499165 | 0.71 | — | — | |
| SCHEMBL9241490 | 0.67 | — | — | |
| SCHEMBL8196838 | 0.67 | — | — | |
| SCHEMBL12004025 | 0.67 | — | — | |
| SCHEMBL3804649 | 0.64 | — | — | |
| SCHEMBL14878887 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200223871-A1 | Arginase Inhibitors and Methods of Use | ASTRAZENECA AB (SE) | 2020-07-16 | — | — | US | disclosed |
| EP-2389352-B1 | ARGINASE INHIBITORS AND METHODS OF USE | UNIV PENNSYLVANIA (US) | 2019-05-08 | — | — | EP | disclosed |
| US-20190127395-A1 | Arginase Inhibitors and Methods of Use | ASTRAZENECA AB (SE) | 2019-05-02 | — | — | US | disclosed |
| US-10118936-B2 | Arginase inhibitors and methods of use | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2018-11-06 | — | — | US | disclosed |
| US-20160194340-A1 | ARGINASE INHIBITORS AND METHODS OF USE | UNIV PENNSYLVANIA (US) | 2016-07-07 | — | — | US | disclosed |
| EP-2389352-A2 | ARGINASE INHIBITORS AND METHODS OF USE | The Trustees Of The University Of Pennsylvania (US) | 2011-11-30 | — | — | EP | disclosed |
| US-8040818-B2 | Method for exchange of upkeep-relevant information with a computer-supported, upkeep system | ENDRESS + HAUSER PROCESS SOLUTIONS AG (CH) | 2011-10-18 | — | — | US | disclosed |
| US-20100189644-A1 | ARGINASE INHIBITORS AND METHODS OF USE | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2010-07-29 | — | — | US | disclosed |
| WO-2010085797-A2 | ARGINASE INHIBITORS AND METHODS OF USE | THE TRUSTEES OF UNIVERSITY OF PENNSYLVANIA (US) | 2010-07-29 | — | — | WO | disclosed |
| EP-1572197-B1 | 4- 1- (SULFONYL) -1H-INDOL-2-YL)-4- (HYDROXY) -CYCLOHEXA-2,5-DIENONE COMPOUNDS AND ANALOGS THEREOF AS THERAPEUTIC AGENTS | CANCER REC TECH LTD (GB) | 2009-07-29 | — | — | EP | disclosed |
| US-7307099-B2 | 4-(1-(sulfonyl)-1h-indol-2-yl)-4-(hydroxy)-cyclohexa-2,5-dienone compounds and analogs thereof as therapeutic agents | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2007-12-11 | — | — | US | disclosed |
| US-20060100265-A1 | 4-(1-(sulfonyl)-1h-indol-2-yl)-4-(hydroxy)-cyclohexa-2,5-dienone compounds and analogs thereof as therapeutic agents | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2006-05-11 | — | — | US | disclosed |
| EP-1572197-A1 | 4- 1- (SULFONYL) -1H-INDOL-2-YL)-4- (HYDROXY) -CYCLOHEXA-2,5-DIENONE COMPOUNDS AND ANALOGS THEREOF AS THERAPEUTIC AGENTS | Cancer Research Technology Limited (GB) | 2005-09-14 | — | — | EP | disclosed |
| WO-2004056361-A1 | 4-(1-(SULFONYL)-1H-INDOL-2-YL)-4-(HYDROXY)-CYCLOHEXA-2,5-DIENONE COMPOUNDS AND ANALOGS THEREOF AS THERAPEUTIC AGENTS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2004-07-08 | — | — | WO | disclosed |
| US-5510475-A | ATTACHMENT OF REPORTERS BY WAY OF PHOSPHONAMIDATE LINKERS, HAVING PROTECTED HYDROXYL OR AMINO FUNCTIONALITY | HYBRIDON, INC. (US) | 1996-04-23 | — | — | US | disclosed |
| EP-0556301-A1 | INCORPORATION OF MULTIPLE REPORTER GROUPS ON SYNTHETIC OLIGONUCLEOTIDES | HYBRIDON, Inc. (US) | 1993-08-25 | — | — | EP | disclosed |
| WO-1992008728-A1 | INCORPORATION OF MULTIPLE REPORTER GROUPS ON SYNTHETIC OLIGONUCLEOTIDES | HYBRIDON, INC. (US) | 1992-05-29 | — | — | WO | disclosed |
| US-4756998-A | Ethylenically unsaturated complex containing at least one urethane or urea group | AGFA GEVAERT AKTIENGESELLSCHAFT (DE) | 1988-07-12 | — | — | US | disclosed |